Gruppo Italiano per lo Studio Della Streptochinasi ‘nell Infarto
miocardico (GISSI). Effectiveness of intravenous thrombolytic treatment in acute myocardial
ISIS-2 (Second International Study of Infarct Survival) Collaborative
Group. Randomized trial of intravenous streptokinase, oral aspirin, both,
or neither among 17,187 cases of suspected acute myocardial infarction. Lancet.1988;2:349-360.
Fibrinolytic Therapy Trialist's (FTT) Collaborative Group. Indications for fibrinolytic therapy in suspected acute myocardial
The GUSTO Investigators. An international randomized trial comparing four thrombolytic strategies
for acute myocardial infarction. N Engl J Med.1993;329:673-682.
Gibbons RJ, Holmes DR, Reeder GS.
et al. Immediate angioplasty compared with the administration of a thrombolytic
agent followed by conservative treatment for myocardial infarction. N Engl J Med.1993;328:685-691.
Grines CL, Browne KF, Marco J.
et al. A comparison of immediate angioplasty with thrombolytic therapy for
acute myocardial infarction. N Engl J Med.1993;328:673-679.
Zijlstra F, de Boer MJ, Hoorntje JCA.
et al. A comparison of immediate coronary angioplasty with intravenous streptokinase
in acute myocardial infarction. N Engl J Med.1993;328:680-684.
O'Neil W, Timmis GC, Bourdillon PD.
et al. A prospective randomized clinical trial of intracoronary streptokinase
versus coronary angioplasty for acute myocardial infarction. N Engl J Med.1986;314:812-818.
Every NR, Parsons LS, Hlatky M, Martin JS, Weaver WD.for the Myocardial Infarction Triage and Intervention Investigators. Comparison of thrombolytic therapy with primary coronary angioplasty
for acute myocardial infarction. N Engl J Med.1996;335:1253-1260.
Tiefenbrunn AJ, Chandra NC, French WJ, Gore JM, Rogers WJ. Clinical experience with primary percutaneous transluminal coronary
angioplasty compared with alteplase (recombinant tissue-type plasminogen activator)
in patients with acute myocardial infarction. J Am Coll Cardiol.1998;31:1240-1245.
Danchin N, Vaur L, Genes N.
et al. Treatment of acute myocardial infarction by primary coronary angioplasty
or intravenous thrombolysis in the "real world." Circulation.1999;99:2639-2644.
Rogers WJ, Dean LS, Moore PB.
et al. Comparison of primary angioplasty versus thrombolytic therapy for acute
myocardial infarction. Am J Cardiol.1994;74:111-118.
Ryan TJ, Anderson JL, Antman EM.
et al. ACC/AHA guidelines for the management of patients with acute myocardial
infarction. J Am Coll Cardiol.1996;28:1328-1428.
Ryan TJ, Antman EM, Brooks NH.
et al. 1999 update: ACC/AHA guidelines for the management of patients with
acute myocardial infarction. Circulation.1999;100:1016-1030.
Rogers WJ, Bowlby LJ, Chandra NC.
et al. Treatment of myocardial infarction in the United States (1990 to 1993). Circulation.1994;90:2103-2114.
Barron HV, Bowlby LJ, Breen T.
et al. for the National Registry of Myocardial Infarction 2 Investigators. Use of reperfusion therapy for acute myocardial infarction in the United
Every NR, Fredrick PD, Robinson M, Sugarman J, Bowlby L, Barron HV. A comparison of the National Registry of Myocardial Infarction 2 with
the Cooperative Cardiovascular Project. J Am Coll Cardiol.1999;33:1886-1894.
Liang K-Y, Zeger SL. Longitudinal data analysis using generalized linear models. Biometrika.1986;73:13-22.
Karim MR, Zeger SL. GEE: A SAS Macro for Longitudinal Data Analysis. Baltimore, Md: Dept of Biostatistics, Johns Hopkins University; 1988.
Technical report 674.
Brophy JM, Joseph L. Placing trials in context using Bayesian analysis. JAMA.1995;273:871-875.
Thiemann DR, Coresh J, Oetgen WJ.
et al. The association between hospital volume and survival after acute myocardial
infarction in elderly patients. N Engl J Med.1999;340:1640-1648.
Kimmel SE, Berlin JA, Laskey WK. The relationship between coronary angioplasty procedure volume and
major complications. JAMA.1995;274:1137-1142.
Jollis JG, Peterson ED, Nelson CL.
et al. Relationship between physician and hospital coronary angioplasty volume
and outcome in elderly patients. Circulation.1997;96:2485-2491.
Hannan EL, Racz M, Ryan TJ.
et al. Coronary angioplasty volume-outcome relationships for hospitals and
Jollis GJ, Peterson ED, DeLong ER.
et al. The relation between the volume of coronary angioplasty procedures
at hospitals treating medicare beneficiaries and short-term mortality. N Engl J Med.1994;331:1625-1629.
Luft HS, Bunker JP, Enthoven AC. Should operations be regionalized? N Engl J Med.1979;301:1364-1369.
Hannan EL, O'Donnell JF, Kilburn Jr H.
et al. Investigation of the relationship between volume and mortality for
surgical procedures performed in New York State hospitals. JAMA.1989;262:503-510.
Hannan EL, Kilburn Jr H, Bernard H.
et al. Coronary artery bypass surgery: the relationship between inhospital
mortality rate and surgical volume after controlling for clinical risk factors. Med Care.1991;29:1094-1107.
Hannan EL, Siu AL, Kumar D.
et al. The decline in coronary artery bypass graft surgery mortality in New
York State. JAMA.1995;273:209-213.
Wilson JM, Menkhaus P, Gustin BW. Volume and outcome of coronary artery bypass graft surgery. JAMA.1987;257:2434-2435.
Luft HS, Romano PS. Chance, continuity, and change in hospital mortality rates. JAMA.1993;270:331-337.
Canto JG, Every NR, Magid DM.
et al. Relation between the volume of primary angioplasty procedures and survival
in acute myocardial infarction. N Engl J Med.2000;342:1573-1580.
The Global Use of Strategies to Open Occluded Coronary Arteries in
Acute Coronary Syndromes (GUSTO IIB) Angioplasty Substudy Investigators. A clinical trial comparing primary coronary angioplasty with tissue
plasminogen activator for acute myocardial infarction. N Engl J Med.1997;336:1621-1628.
Zijlstra F, Hoorntje JCA, de Boer M-J.
et al. Long-term benefit of primary angioplasty as compared with thrombolytic
therapy for acute myocardial infarction. N Engl J Med.1999;341:1413-1419.